NSE - Delayed Quote INR

Blue Jet Healthcare Limited (BLUEJET.NS)

725.65
+2.35
+(0.32%)
At close: 3:30:03 PM GMT+5:30
Loading Chart for BLUEJET.NS
  • Previous Close 723.30
  • Open 707.00
  • Bid --
  • Ask --
  • Day's Range 702.10 - 729.40
  • 52 Week Range 347.60 - 968.30
  • Volume 120,036
  • Avg. Volume 479,477
  • Market Cap (intraday) 125.892B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 53.63
  • EPS (TTM) 13.53
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield 1.00 (0.14%)
  • Ex-Dividend Date Sep 18, 2024
  • 1y Target Est 855.83

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.

www.bluejethealthcare.com

447

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BLUEJET.NS

View More

Performance Overview: BLUEJET.NS

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BLUEJET.NS
28.50%
S&P BSE SENSEX (^BSESN)
1.68%

1-Year Return

BLUEJET.NS
91.35%
S&P BSE SENSEX (^BSESN)
9.74%

3-Year Return

BLUEJET.NS
90.96%
S&P BSE SENSEX (^BSESN)
45.87%

5-Year Return

BLUEJET.NS
90.96%
S&P BSE SENSEX (^BSESN)
151.10%

Compare To: BLUEJET.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BLUEJET.NS

View More

Valuation Measures

Annual
As of 5/8/2025
  • Market Cap

    125.58B

  • Enterprise Value

    121.85B

  • Trailing P/E

    53.42

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    14.38

  • Price/Book (mrq)

    13.58

  • Enterprise Value/Revenue

    13.97

  • Enterprise Value/EBITDA

    36.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.88%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.73B

  • Net Income Avi to Common (ttm)

    2.35B

  • Diluted EPS (ttm)

    13.53

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.64B

  • Total Debt/Equity (mrq)

    0.12%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: BLUEJET.NS

View More

Company Insights: BLUEJET.NS

Research Reports: BLUEJET.NS

View More

People Also Watch